Nektar Therapeutics
NKTR
#4620
Rank
NZ$4.15 B
Marketcap
NZ$122.99
Share price
6.76%
Change (1 day)
190.38%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): NZ-$17.49

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$17.97. In 2024 the company made an earnings per share (EPS) of NZ-$15.61 an increase over its 2023 EPS that were of NZ-$38.58.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$17.4912.05%
2024NZ-$15.61-59.54%
2023NZ-$38.58-25.89%
2022NZ-$52.06-31.12%
2021NZ-$75.5814.86%
2020NZ-$65.80-1.19%
2019NZ-$66.60-163.96%
2018NZ$104.12-725.4%
2017NZ-$16.65-42.73%
2016NZ-$29.0783.33%
2015NZ-$15.8639.53%
2014NZ-$11.36-69.29%
2013NZ-$37.00-6.67%
2012NZ-$39.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.39-185.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.31-112.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$25.51-241.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$3.75-79.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.27-134.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$12.24-168.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$0.12-100.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$1.64-109.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland